Literature DB >> 11024132

Severe murine lung immunopathology elicited by the pathogenic equine herpesvirus 1 strain RacL11 correlates with early production of macrophage inflammatory proteins 1alpha, 1beta, and 2 and tumor necrosis factor alpha.

P M Smith1, Y Zhang, W D Grafton, S R Jennings, D J O'Callaghan.   

Abstract

The CBA mouse model was used to investigate the immunopathology induced in the lung by the pathogenic equine herpesvirus 1 (EHV-1) strain RacL11 in comparison to infection with the attenuated vaccine candidate strain KyA. Intranasal infection with KyA resulted in almost no inflammatory infiltration in the lung. In contrast, infection with the pathogenic RacL11 strain induced a severe alveolar and interstitial inflammation, consisting primarily of lymphocytes, macrophages, and neutrophils. Infection with either EHV-1 strain resulted in the accumulation of similar numbers and ratios of CD4 and CD8 T lymphocytes in the lung and bronchoalveolar lavage (BAL) fluid. Further analysis of these T-cell populations revealed identical EHV-1-specific cytotoxic T-lymphocyte responses. RNase protection analysis of RNA isolated from the BAL fluid of RacL11-infected mice on day 3 postinfection revealed much higher levels of RNA specific for macrophage inflammatory protein 1alpha (MIP-1alpha), MIP-1beta, and MIP-2 than were observed for KyA-infected mice. Furthermore, significantly higher levels of transcripts specific for tumor necrosis factor alpha were induced on day 3 postinfection with RacL11 compared with KyA. These findings suggest that the early production of proinflammatory beta chemokines plays a major role in the severe, most often lethal, respiratory inflammatory response induced by the pathogenic EHV-1 strain RacL11.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11024132      PMCID: PMC102042          DOI: 10.1128/jvi.74.21.10034-10040.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  Respiratory syncytial virus induces selective production of the chemokine RANTES by upper airway epithelial cells.

Authors:  T Saito; R W Deskin; A Casola; H Häeberle; B Olszewska; P B Ernst; R Alam; P L Ogra; R Garofalo
Journal:  J Infect Dis       Date:  1997-03       Impact factor: 5.226

2.  Lack of virulence of the murine fibroblast adapted strain, Kentucky A (KyA), of equine herpesvirus type 1 (EHV-1) in young horses.

Authors:  T Matsumura; D J O'Callaghan; T Kondo; M Kamada
Journal:  Vet Microbiol       Date:  1996-02       Impact factor: 3.293

3.  The equine herpesvirus 1 IR6 protein influences virus growth at elevated temperature and is a major determinant of virulence.

Authors:  N Osterrieder; A Neubauer; C Brandmüller; O R Kaaden; D J O'Callaghan
Journal:  Virology       Date:  1996-12-15       Impact factor: 3.616

4.  Transcriptional analyses of the unique short segment of EHV-1 strain Kentucky A.

Authors:  C F Colle; D J O'Callaghan
Journal:  Virus Genes       Date:  1995-02       Impact factor: 2.332

5.  Responses of ponies to equid herpesvirus-1 ISCOM vaccination and challenge with virus of the homologous strain.

Authors:  D Hannant; D M Jessett; T O'Neill; C A Dolby; R F Cook; J A Mumford
Journal:  Res Vet Sci       Date:  1993-05       Impact factor: 2.534

6.  Role of T-cells, virus neutralising antibodies and complement-mediated antibody lysis in the immune response against equine herpesvirus type-1 (EHV-1) infection of C3H (H-2k) and BALB/c (H-2d) mice.

Authors:  D G Alber; J Greensill; R A Killington; A Stokes
Journal:  Res Vet Sci       Date:  1995-11       Impact factor: 2.534

7.  Regulation of human decidual cell macrophage inflammatory protein-1 alpha (MIP-1 alpha) production by inflammatory cytokines.

Authors:  D J Dudley; S Spencer; S Edwin; M D Mitchell
Journal:  Am J Reprod Immunol       Date:  1995-10       Impact factor: 3.886

8.  Protective antibody therapy is associated with reduced chemokine transcripts in herpes simplex virus type 1 corneal infection.

Authors:  Y H Su; X T Yan; J E Oakes; R N Lausch
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

Review 9.  Macrophage inflammatory proteins: biology and role in pulmonary inflammation.

Authors:  K E Driscoll
Journal:  Exp Lung Res       Date:  1994 Nov-Dec       Impact factor: 2.459

10.  The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis.

Authors:  K Saukkonen; S Sande; C Cioffe; S Wolpe; B Sherry; A Cerami; E Tuomanen
Journal:  J Exp Med       Date:  1990-02-01       Impact factor: 14.307

View more
  10 in total

1.  Intramuscular Immunization of Mice with the Live-Attenuated Herpes Simplex Virus 1 Vaccine Strain VC2 Expressing Equine Herpesvirus 1 (EHV-1) Glycoprotein D Generates Anti-EHV-1 Immune Responses in Mice.

Authors:  Shiliang A Liu; Brent A Stanfield; Vladimir N Chouljenko; Shan Naidu; Ingeborg Langohr; Fabio Del Piero; Jacqueline Ferracone; Alma A Roy; Konstantin G Kousoulas
Journal:  J Virol       Date:  2017-05-26       Impact factor: 5.103

2.  Immunization with Attenuated Equine Herpesvirus 1 Strain KyA Induces Innate Immune Responses That Protect Mice from Lethal Challenge.

Authors:  Seong K Kim; Akhalesh K Shakya; Dennis J O'Callaghan
Journal:  J Virol       Date:  2016-08-26       Impact factor: 5.103

3.  Fatal outcome of pandemic H1N1 2009 influenza virus infection is associated with immunopathology and impaired lung repair, not enhanced viral burden, in pregnant mice.

Authors:  Glendie Marcelin; Jerry R Aldridge; Susu Duan; Hazem E Ghoneim; Jerold Rehg; Henju Marjuki; Adrianus C M Boon; Jonathan A McCullers; Richard J Webby
Journal:  J Virol       Date:  2011-08-24       Impact factor: 5.103

4.  Expression of the full-length form of gp2 of equine herpesvirus 1 (EHV-1) completely restores respiratory virulence to the attenuated EHV-1 strain KyA in CBA mice.

Authors:  Patrick M Smith; Shannon M Kahan; Colin B Rorex; Jens von Einem; Nikolaus Osterrieder; Dennis J O'Callaghan
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

5.  Intranasal treatment with CpG-B oligodeoxynucleotides protects CBA mice from lethal equine herpesvirus 1 challenge by an innate immune response.

Authors:  Seong K Kim; Akhalesh K Shakya; Dennis J O'Callaghan
Journal:  Antiviral Res       Date:  2019-06-25       Impact factor: 5.970

6.  CCL3 and viral chemokine-binding protein gg modulate pulmonary inflammation and virus replication during equine herpesvirus 1 infection.

Authors:  Gerlinde R Van de Walle; Kaori Sakamoto; Nikolaus Osterrieder
Journal:  J Virol       Date:  2007-12-12       Impact factor: 5.103

7.  The UL4 protein of equine herpesvirus 1 is not essential for replication or pathogenesis and inhibits gene expression controlled by viral and heterologous promoters.

Authors:  Robert A Charvat; Jonathan E Breitenbach; ByungChul Ahn; Yunfei Zhang; Dennis J O'Callaghan
Journal:  Virology       Date:  2011-02-15       Impact factor: 3.513

8.  Comparative Genomic Sequencing and Pathogenic Properties of Equine Herpesvirus 1 KyA and RacL11.

Authors:  Akhalesh K Shakya; Dennis J O'Callaghan; Seong K Kim
Journal:  Front Vet Sci       Date:  2017-12-11

9.  Interferon Gamma Inhibits Equine Herpesvirus 1 Replication in a Cell Line-Dependent Manner.

Authors:  Seong K Kim; Akhalesh K Shakya; Dennis J O'Callaghan
Journal:  Pathogens       Date:  2021-04-16

10.  Characterizing the Pathogenesis and Immune Response of Equine Herpesvirus 8 Infection in Lung of Mice.

Authors:  Leyu Hu; Tongtong Wang; Huiying Ren; Wenqiang Liu; Yubao Li; Changfa Wang; Liangliang Li
Journal:  Animals (Basel)       Date:  2022-09-20       Impact factor: 3.231

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.